Indications |
Inhalation Induction and maintenance of general anaesthesia Adult: Induction: 2-4% v/v of halothane in O2 or mixtures of nitrous oxide and O2. Alternatively, 0.5% v/v of halothane may be used for induction and gradually increased to the required level for maintenance of anaesthesia. Maintain anesthesia at 0.5-2% v/v depending on the flow rate used. Child: Induction: 1.5-2% v/v. Maintenance of anaesthesia: 0.5-2% v/v depending on the flow rate used. Incompatibility: Reacts with many metals when in contact with moisture. Rubber and some plastics deteriorate when in contact with halothane vapour or liquid. |
Contraindications |
Obstetrics; malignant hyperthermia; porphyria. |
Warnings / Precautions |
Phaeochromocytoma; poor cardiac/liver function, early pregnancy. Premedication with atropine is recommended to decrease vagal tone and prevent bradycardia and severe hypotension. May trigger malignant hyperthermia and increase intracranial pressure. Increased risk of hyperkalaemia in paediatrics with underlying neuromuscular disorders. May reduce hepatic, renal and splenic blood flow. |
Adverse Reactions |
Bradycardia, hypotension, cardiac arrhythmias, respiratory depression, shivering during recovery (occasional), hepatitis (multiple exposure). Potentially Fatal: Fulminant hepatic failure, malignant hyperpyrexia and pulmonary oedema. |
Overdose Reactions |
Bradycardia and profound hypotension. |
Drug Interactions |
Adrenaline, other sympathomimetics, and theophylline can produce cardiac arrhythmias. Morphine and chlorpromazine may increase depressant effects of halothane on respiration. Increased risk of phenytoin intoxication when used together. Midazolam may potentiate the anaesthetic action of halothane. Potentially Fatal: Dopaminergics increase the risk of ventricular arrhythmias. Neuromuscular blocking drugs are potentiated by halothane. See Below for More halothane Drug Interactions |
Mechanism of Actions |
Halothane causes reversible CNS depression; sympathetic system is more depressed than the parasympathetic. Respiration is progressively depressed. BP, heart rate, cardiac output and coronary blood flow are reduced. Absorption: Well absorbed (inhalation). Distribution: Soluble in the neutral fats of adipose tissue. Crosses the placenta and enters breast milk. Metabolism: Hepatic; converted to trifluoroacetic acid, bromide and chloride salts (oxidative pathway) and fluoride salts (reductive pathway). Excretion: Lungs (as unchanged drug). |
Storage Conditions |
Inhalation: Store at 15-25°C. |
ATC Classification |
N01AB01 - halothane ; Belongs to the class of halogenated hydrocarbons. Used as general anesthetics. |
Storage |
Inhalation: Store at 15-25°C. |
Available As |
|
Halothane
Post Review about Halothane Click here to cancel reply.
Halothane Containing Brands
Halothane is used in following diseases
Drug - Drug Interactions of Halothane
Latest News
- FDA approves Ruconest for treatment of hereditary angioedema
- FDA recommend against aspirin to prevent First Heart Attacks
- FDA approves Pomalyst (pomalidomide) for advanced multiple myeloma
- FDA approves three new drug treatments for type 2 diabetes
- Long-term consequences of vaginal delivery on the pelvic floor
No comments yet.